Loading…

Loading grant details…

Completed HORIZON European Commission

Automatic vein wall disruption, triggering the body’s natural cellular healing response to close targeted veins curing Venous Leg Ulcers

€3.61M EUR

Funder European Commission
Recipient Organization Invera Medical Limited
Country Ireland
Start Date Oct 01, 2022
End Date Sep 30, 2024
Duration 730 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190175560
Grant Description

Chronic venous disease is one of the most common diseases in the developed world, affecting up to 60% of adults over the age of 50.

Chronic venous disease is the leading cause of Venous Leg Ulcers which are chronic open sores, usually on the inside of the leg that will not heal without specialist treatment.

The total costs associated with managing venous disease patients across Europe and the US is 33.4 billion per year, representing 2.5% of total healthcare expenditure.Most patients are treated with ineffective compression bandaging which does not treat the underlying cause and has an unacceptably high recurrence rate.

These bandages are also sent to landfill with a high environmental impactEnVena is the worlds first device to mimic the bodys natural healing response to deliver an effective treatment to venous leg ulcer patients.

All Grantees

Invera Medical Limited

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant